Berkshire Hathaway vs UBS Lux Equity Fund Biotech USD

Berkshire Hathaway vs UBS Lux Equity Fund Biotech USD

1. Berkshire Hathaway

  • Security

    Berkshire Hathaway Inc Class A

  • ISIN

    US0846701086

  • Holdings

    9

2. UBS Lux Equity Fund Biotech USD

  • Security

    UBS Lux Equity Fund Biotech USD P-acc

  • Fee

    2.25%

  • ISIN

    LU0069152568

  • Holdings

    10

Fund Holdings

We have information about 16 holdings in Berkshire Hathaway, where the largest holding is Apple (21.1), followed by American Express (14.3) and Coca-Cola (11.2). In comparison with UBS Lux Equity Fund Biotech USD, we have 14 holdings where Regeneron Pharmaceuticals is the largest holding (10.04), followed by Vertex (9.9) and Moderna (9.21).

All Holdings

Here we compare the holdings in Berkshire Hathaway and UBS Lux Equity Fund Biotech USD.

Berkshire Hathaway UBS Lux Equity Fund Biotech USD
1. Apple Inc
USA
21.1 %
1. Regeneron Pharmaceuticals Inc
10.04 %
2. American Express Co
USA
14.3 %
2. Vertex Pharmaceuticals Inc
9.9 %
3. Coca-Cola Company
USA
11.2 %
3. Moderna Inc
9.21 %
4. Bank of America Corp
USA
9.7 %
4. Alnylam Pharmaceuticals Inc
6.54 %
5. Chevron Corp
USA
6.6 %
5. AbbVie Inc
USA
5.52 %
6. Moody's Corp
USA
4 %
6. Gilead Sciences Inc
USA
4.66 %
7. Occidental Petroleum Corp
USA
3.9 %
7. Amgen Inc
4.32 %
8. Kraft Heinz Co
3.7 %
8. BioNTech SE
4.13 %
9. Chubb Ltd
3 %
9. Karuna Therapeutics Inc
3.75 %
- 10. Royalty Pharma Plc
3.28 %

The list of fund holdings was last updated on April 17, 2025.